June 30, 2026 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces the completion of a combined royalty financing and equity investment (the “Transaction”) with Ligand Pharmaceuticals, Incorporated, (“Ligand”), listed on US NASDAQ under the ticker LGND.Under the terms of the Transact…
Company announcement no. 23 - 2630 June 2026Transactions in connection with share buy-back programOn 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company announcement no. 3 - 26. The program will be executed in accordance with the principles of…
By Adria CalatayudA.P. Moller-Maersk shares traded higher after the Danish shipping group lifted its full-year guidance, citing continued strong demand and a sustained increase in freight rates.Shares in Maersk rose as much as 5.4% in early European morning trading before pulling back, adding to ga…
Brøndbyernes I.F. Fodbold A/S har ansat Søren Kristensen som ny administrerende direktør (Chief Executive Officer). Søren Kristensen tiltræder stillingen senest pr. 1. september.Søren Kristensen kommer fra en stilling som administrerende direktør for Hotel- og Restaurantskolen og har i en årrække f…
Huddlestock Fintech AS ("Huddlestock" or the "Company"), a leading investment technology and services provider, has through its consulting business, Visigon, expanded its existing relationship with a large Danish bank and mortgage institution.“This extension highlights our ability to grow organical…
By Paul VieiraOTTAWA--Canadian regulators approved Apotex's bid to manufacture a generic version of the weight-loss drug Wegovy.Canada's health department, which is in charge of drug approvals, said Monday it authorized Apotex's bid following a review of evidence from the company that meets the reg…
Company AnnouncementCOPENHAGEN, Denmark; June 29, 2026 – Genmab A/S NASDAQ:GMAB today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of fixed duration epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, and lenalidomide, compar…
Pursuant to the Market Abuse Regulation article 19, Better Collective A/S (the “Company”), CVR no. 27652913, hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in the Company and persons closely associated with them in Better…
ANNOUNCEMENTA.P. Møller - Mærsk A/S – Upgrade of guidance for the full year 2026Guidance for full year 2026Continued strong demand in the container market, particularly in the Far East, and a recent sustained increase in spot market rates means that A.P. Møller – Mærsk A/S (APMM) upgrades its guida…
Novo Nordisk NVO and Viking Therapeutics VKTX are both riding on the powerful growth trend in obesity care, a market expected to expand significantly as demand for effective weight-loss treatments continues to rise. While NVO has already established itself as a leader with blockbuster GLP-1 therapi…
Company announcement No. 28 / 2026Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)Copenhagen, Denmark, June 29, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) NASDAQ:ZEAL (CVR-no. 20045078), a biotechnology company transforming the future of metabolic h…
Bagsværd, Denmark, 29 June 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe…
Dear SirsAL Sydbank A/S share buyback programme: transactions in week 26On 25 February 2026 AL Sydbank A/S announced a share buyback programme of DKK 1,100m. The share buyback programme commenced on 2 March 2026 and will be completed by 31 January 2027.The purpose of the share buyback programme is…
On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026.The buy-back will be structured in acc…
ANNOUNCEMENTA.P. Møller - Mærsk A/S – Transactions in connection with share buy-back programOn 5 February 2026, A.P. Møller - Mærsk A/S (the “Company”) announced a share buy-back program of up to DKK 6.3bn (around USD 1bn) to be executed over a period of 12 months. The first phase of the share buy…
Copenhagen, Denmark, 29 June 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company maximizing surgical outcomes in oncology by lighting up cancer, today announced positive results from the first part of its ongoing FG001-CT-005 Phase 2 trial evaluating FG001 for surgical guidance i…
COMPANY ANNOUNCEMENT NO 35/2026 - June 29, 2026On February 26, 2026, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 3/2026. On April 30, 2026, the program was increased from a maximum of DKK 400m to DKK 700m, cf. company announcement no. 23/2026.The share buy-back pr…
To Nasdaq Copenhagen A/S 29 June 2026Announcement no. 56/2026Inside informationPreliminary data on early redemptions (prepayments)Pursuant to S. 24 of the Capital Markets Act, we hereby publish preliminary data on early redemptions (prepayments) in bonds issued by Jyske Realkredit. Please find the…
Danske Bank share buy-back programme: transactions in week 26On 5 February 2026, Danske Bank A/S announced a share buy-back programme for a total of DKK 4.5 billion, with a maximum of 45,000,000 shares, in the period from 9 February 2026 to 29 January 2027, at the latest, as described in company an…
Company announcementNo. 39/2026 29 June 2026Transactions in connection with share buyback programmeOn 3 February 2026, Netcompany Group A/S (“Netcompany”) announced that a share buyback programme of up to DKK 750m and a maximum of 3,250,000 shares had been initiated with the purpose of adjusting Ne…